Our results indicated that TFRC expression was elevated in 12 tumor types compared to their respective normal tissues, including bladder (BLCA), breast (BRCA), cervical (CESC), cholangiocarcinoma (CHOL), colon (COAD), esophageal (ESCA), glioblastoma (GBM), head and neck squamous cell carcinoma (HNSC), liver (LIHC), lung (LUSC), stomach (STAD), and uterine (UCEC) cancers. Here, TFRC is linked to neoplasm.